EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects

Hans Van der Eecken iD, Steven Joniau iD, Charlien Berghen iD, Kato Rans, Gert De Meerleer

Nutrients · 21.11.2023 · 15 (23) · 4856

DOI: 10.3390/nu15234856 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 21.11.2023. Verfasst von Hans Van der Eecken und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital Brussels, 1090 Brussels, Belgium. Hauptthemen laut MEDLINE: Isoflavones, Prostatic Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A possible link between diet and cancer has long been considered, with growing interest in phytochemicals. Soy isoflavones have been associated with a reduced risk of prostate cancer in Asian populations. Of the soy isoflavones, genistein and daidzein, in particular, have been studied, but recently, equol as a derivative has gained interest because it is more biologically potent. Different mechanisms of action have already been studied for the different isoflavones in multiple conditions, such as breast, gastrointestinal, and urogenital cancers. Many of these mechanisms of action could also be demonstrated in the prostate, both in vitro and in vivo. This review focuses on the known mechanisms of action at the cellular level and compares them between genistein, daidzein, and equol. These include androgen- and estrogen-mediated pathways, regulation of the cell cycle and cell proliferation, apoptosis, angiogenesis, and metastasis. In addition, antioxidant and anti-inflammatory effects and epigenetics are addressed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoflavonesProstatic NeoplasmsMaleHumansGenisteinEquolGlycine max

Stichwörter der Autor:innen

daidzeinequolgenisteinisoflavoneprostate cancer

Substanzen

GenisteinEquolIsoflavones

Autor:innen und Institutionen

  • Department of Urology, University Hospital Brussels, 1090 Brussels, Belgium.
  • Department of Urology, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Department of Radiation Oncology, University Hospitals Leuven, 3000 Leuven, Belgium.

ORCID-Profile: Hans Van der Eecken, Steven Joniau, Charlien Berghen

Zitieren

APA

Van der Eecken, H., Joniau, S., Berghen, C., Rans, K., & De Meerleer, G. (2023). The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects. Nutrients, 15(23), 4856. https://doi.org/10.3390/nu15234856

Vancouver

Van der Eecken H, Joniau S, Berghen C, Rans K, De Meerleer G. The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects. Nutrients. 2023;15(23):4856. doi:10.3390/nu15234856

BibTeX
@article{VanderEecken2023,
  author = {Van der Eecken, Hans and Joniau, Steven and Berghen, Charlien and Rans, Kato and De Meerleer, Gert},
  title = {The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {23},
  pages = {4856},
  doi = {10.3390/nu15234856}
}
Kostenlos starten →